Abpro Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Trials    News 
  • ||||||||||  ABP-300 / Abpro Therap, BIO invest, Mabwell (Shanghai) Biosci
    Clinical; Trial completion:  A Clinical Study to Evaluate MW33 Injection (clinicaltrials.gov) -  Feb 24, 2021   
    P1,  N=42, Completed, 
    Active, not recruiting -> Completed
  • ||||||||||  ABP-300 / Abpro Therap, BIO invest, Mabwell (Shanghai) Biosci
    Clinical; Enrollment change; Enrollment closed:  A Clinical Study to Evaluate MW33 Injection (clinicaltrials.gov) -  Sep 1, 2020   
    P1,  N=42, Active, not recruiting, 
    Recruiting -> Active, not recruiting | N=32 -> 42
  • ||||||||||  ABP-300 / Abpro Therap, BIO invest, Mabwell (Shanghai) Biosci
    Clinical; New P1 trial:  A Clinical Study to Evaluate MW33 Injection (clinicaltrials.gov) -  Aug 22, 2020   
    P1,  N=42, Recruiting,